Utilizing an acute hyperthermia‐induced seizure test and pharmacokinetic studies to establish optimal dosing regimens in a mouse model of Dravet syndrome

Documenti analoghi

• Development of a preclinical testing platform for clinically relevant therapy for Dravet syndrome
  di: Jeffrey A. Mensah, et al.
  Pubblicazione: (2025)
• Pharmacological management of prolonged seizures in Dravet syndrome including intravenous phenytoin
  di: Rana Abi Tayeh, et al.
  Pubblicazione: (2024)
• Lack of effectiveness and seizure worsening with cenobamate in pediatric patients with Dravet syndrome
  di: Rita Cagigal, et al.
  Pubblicazione: (2025)
• Long‐lasting remodeling of astrocytes in an Scna1 +/− mouse model of Dravet syndrome
  di: Athénaïs Genin, et al.
  Pubblicazione: (2026)
• Correction to “Metabolomic signature of the Dravet syndrome: A genetic mouse model study”
  Pubblicazione: (2025)